NCT01516606View on ClinicalTrials.gov

Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions
Lymphoma
Interventions
DRUG

clarithromycin, oral, high dose

2 g/day clarithromycin (once a day) for 14 days followed by 7 days interval to be repeated for 4 cycles in total

Trial Locations (1)

Unknown

Dpt of OncoHematology - Fondazione Centro San Raffaele del Monte Tabor, Milan

All Listed Sponsors
lead

Andres J. M. Ferreri

OTHER

NCT01516606 - Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma | Biotech Hunter | Biotech Hunter